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Singleton-Merten Syndrome (SMS) is a rare autosomal-dominant disorder characterized by a variety of symptoms 
including extreme calcifications of the ascending aorta and cardiac valves, dental anomalies (early onset 
periodontitis, root resorption), psoriasis and widened medullary cavities of the phalanges with focal osteoporosis. 
Employing whole exome sequencing of five SMS individuals of three families we identified the missense 
mutation, c.2465G>A (p.Arg822Gln) in the interferon induced with helicase C domain 1 (IFIH1) gene. Additional 
Sanger sequencing confirmed co-segregation of the mutation with the disorder. IFIH1, encoding melanoma 
differentiation-associated protein 5 (MDA5), is a member of the RIG-I-like receptor family and functions as a 
cytoplasmic pattern recognition receptor recognizing viral double stranded RNA (dsRNA). Immunohistochemistry 
demonstrated the localization of MDA5 in all affected target tissues including heart, skin and cartilage. Functional 
analysis revealed that the IFIH1 c.2465G>A mutation enhanced MDA5 function in interferon beta induction after 
polyinosinic:polycytidylic acid (poly (I:C)) stimulation in vitro. This indicates that SMS-MDA5 is hyperactive to 
non-self dsRNA. According to additional in vitro studies, interferon signature genes including SIGLEC1 were 
upregulated in blood and dental cells derived from SMS individuals. Taken together, our data demonstrate that the 
MDA5 gain-of-function mutation p.Arg822Gln causes the autosomal dominant disorder SMS through 
dysregulation of the human innate immune response. 
